Table 3.
Overview of different types of enzymatic digestion solutions and cell culture media used in this study
| Name of solution/medium | Use | Ingredients |
|---|---|---|
| Adipose tissue digestion solution |
|
DMEM/F‐12 + 0.13 U mL−1 collagenase type NB4 + 1% (w/v) BSA |
| A wash medium |
|
DMEM/F‐12 + 100 U mL−1 Pen/Strep |
| A base medium |
|
DMEM/F‐12 (incl. glutamine) + 10% (v/v) FCS + 10 µM HEPES + 100 U mL−1 Pen/Strep |
| S/M base medium |
|
A base medium + 10 ng mL−1 GM‐CSF |
| Skin digestion solution |
|
PBS−+ 2.0 /mL Dispase II |
| mvEC expansion medium |
|
ECGM + 10 mg mL−1 Gentamicin |
| PBMC culture medium |
|
X‐VIVO 15 + 10% (v/v) autologous serum + 100 U mL−1 Pen/Strep |
| PBMC freezing medium |
|
10% (v/v) dimethylsulfoxid (DMSO) in FCS |
| PBMC thawing medium |
|
PBMC culture medium + 10 U mL−1 IL‐2 |
| T cell activation medium |
|
PBMC culture medium + 1% (v/v) T Cell TransAct human |
| 2× Monocyte/macrophage culture medium |
|
A base medium + 20 ng mL−1 GM‐CSF |
| A medium |
|
A base medium + 60 nM Insulin + 100 nM Rosiglitazone |
| E medium |
|
ECGM + 100 U mL−1 Pen/Strep |
| E TNF‐α stimulation medium |
|
E medium + 20 ng mL−1 TNF‐α |
| E LPS stimulation medium |
|
E medium + 100 ng mL−1 LPS |
| AE co‐culture medium |
|
A medium:E medium 1:1 |
| AS/AM co‐culture medium |
|
A medium + 10 ng mL−1 GM‐CSF |
| ASE multi‐culture medium |
|
AE co‐culture medium + 10 ng mL−1 GM‐CSF |
| A TNF‐α stimulation medium |
|
A base medium + 20 ng mL−1 TNF‐α |
| AS/AM TNF‐α stimulation medium |
|
A base medium + 10 ng mL−1 GM‐CSF + 20 ng mL−1 TNF‐α |
| ASE TNF‐α stimulation medium |
|
A base medium:E medium 1:1 + 10 ng mL−1 GM‐CSF + 20 ng mL−1 TNF‐α |
| A LPS stimulation medium |
|
A base medium + 100 ng mL−1 LPS |
| AS/AM LPS stimulation medium |
|
A base medium + 10 ng mL−1 GM‐CSF + 100 ng mL−1 LPS |
| ASE LPS stimulation medium |
|
A base medium:E medium 1:1 + 10 ng mL−1 GM‐CSF + 100 ng mL−1 LPS |
| T‐cell perfusion medium |
|
X‐VIVO 15 + 100 U mL−1 Pen/Strep |